Per Richard Torbjörn Hallberg

Per Richard Torbjörn Hallberg

Director/Board Member at DOVA PHARMACEUTICALS, INC.

Net worth: 4 M $ as of 2026-05-30

57 year
Health Technology
Commercial Services
Consumer Services

Profile

Per Richard Torbjörn Hallberg is currently a Director at Takeda Oy, Dova Pharmaceuticals, Inc., Swedish Orphan Biovitrum, Inc., Swedish Orphan Biovitrum (Belgium) SARL, and General Counsel & Head-Legal Affairs at Swedish Orphan Biovitrum AB. Previously, he worked as a Senior Associate at Advokatfirman Lindahl KB, Corporate Counsel at Ferring Pharmaceuticals, Inc., Corporate Counsel at Nycomed AB, and Vice President & General Counsel-Emerging Markets at Takeda AB. He obtained a graduate degree from the University of Lund.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-11 78,949 ( 0.02% ) 4 M $ 2026-05-30

Per Richard Torbjörn Hallberg active positions

CompaniesPositionStart
SWEDISH ORPHAN BIOVITRUM AB General Counsel 2017-12-31
DOVA PHARMACEUTICALS, INC. Director/Board Member 2019-11-11
Director/Board Member 2016-04-30
Director/Board Member -
Director/Board Member 2021-05-31

Former positions of Per Richard Torbjörn Hallberg

CompaniesPositionEnd
Takeda AB
Director/Board Member 2016-12-31
General Counsel 2009-12-31
General Counsel 2003-12-31
Corporate Officer/Principal 2000-12-31
See the detail of Per Richard Torbjörn Hallberg's experience

Training of Per Richard Torbjörn Hallberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

36

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Takeda AB

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Per Richard Torbjörn Hallberg